West Michael D (CIK 0001202529)

Latest company ownership

Shares held
904,851
Last filed at
Sep 19, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2012Q2 2025Q4
Shares held
45,107
Last filed at
Mar 14, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 11, 2023 Mar 14, 2023 Serina Therapeutics, Inc. CEO Sell 27.5 -1,060 -2.46% ✗ $625.4
Dec 11, 2022 Dec 13, 2022 Serina Therapeutics, Inc. CEO Sell 27.5 -1,081 -2.64% ✗ $637.8
Sep 11, 2022 Sep 13, 2022 Serina Therapeutics, Inc. CEO Sell 27.5 -1,081 -2.37% ✗ $607.9
Jun 11, 2022 Jun 14, 2022 Serina Therapeutics, Inc. CEO Sell 27.5 -1,081 -2.48% ✗ $832.6
Mar 11, 2022 Mar 15, 2022 Serina Therapeutics, Inc. CEO Sell 27.5 -1,281 -3.07% ✗ $886.8
Dec 11, 2021 Dec 14, 2021 Serina Therapeutics, Inc. CEO Sell 27.5 -1,081 -2.73% ✗ $686.4
Sep 11, 2021 Sep 21, 2021 Serina Therapeutics, Inc. CEO Sell 27.5 -1,081 -2.87% ✗ $1.1K
Jun 11, 2021 Jun 15, 2021 Serina Therapeutics, Inc. CEO Sell 27.5 -1,081 -3.04% ✗ $1.7K
Mar 11, 2021 Mar 15, 2021 Serina Therapeutics, Inc. CEO Sell 27.5 -1,284 -3.81% ✗ $2.6K
Dec 11, 2020 Dec 15, 2020 Serina Therapeutics, Inc. CEO Sell 27.5 -1,081 -3.41% ✗ $1.8K
Sep 11, 2020 Sep 15, 2020 Serina Therapeutics, Inc. CEO Sell 27.5 -1,081 -3.65% ✗ $875.1
Jun 11, 2020 Jun 15, 2020 Serina Therapeutics, Inc. CEO Sell 27.5 -1,081 -3.92% ✗ $864.9
Mar 11, 2020 Mar 13, 2020 Serina Therapeutics, Inc. CEO Sell 27.5 -5,085 -17.22% ✗ $4.5K
Dec 10, 2018 Dec 12, 2018 Serina Therapeutics, Inc. CEO Buy 91.3 +4,000 34.90% ✗ $15.4K
Sep 17, 2018 Sep 19, 2018 Lineage Cell Therapeutics, Inc. CEO Sell 45.0 -3,783 -0.42% ✗ $8.7K
Jul 10, 2018 Jul 12, 2018 Lineage Cell Therapeutics, Inc. CEO Sell 52.5 -541 -0.06% ✗ $1.2K
Apr 10, 2018 Apr 12, 2018 Lineage Cell Therapeutics, Inc. CEO Sell 52.5 -541 -0.06% ✗ $1.3K
Jan 10, 2018 Jan 12, 2018 Lineage Cell Therapeutics, Inc. CEO Sell 52.5 -686 -0.08% ✗ $1.8K
Oct 10, 2017 Oct 12, 2017 Lineage Cell Therapeutics, Inc. CEO Sell 52.5 -588 -0.07% ✗ $1.7K
Aug 22, 2017 Aug 23, 2017 Lineage Cell Therapeutics, Inc. CEO Buy 60.0 +2,000 0.23% ✗ $5.2K
Jul 10, 2017 Jul 12, 2017 Lineage Cell Therapeutics, Inc. CEO Sell 52.5 -587 -0.07% ✗ $1.8K
Apr 10, 2017 May 1, 2017 Lineage Cell Therapeutics, Inc. CEO Sell 45.0 -2,348 -0.27% ✗ $7.8K
Jul 21, 2014 Jul 23, 2014 Lineage Cell Therapeutics, Inc. CEO Sell 17.5 -704,013 -44.56% ✗ $1.9M
May 31, 2012 May 31, 2012 Lineage Cell Therapeutics, Inc. CEO Buy 91.3 +10,000 10.04% ✗ $40.5K